ClinicalTrials.Veeva

Menu

Erythema Toxicum Neonatorum in Newborns and the Development of Asthma

University of Rochester logo

University of Rochester

Status

Completed

Conditions

Asthma
Erythema Toxicum Neonatorum

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of research addressing this issue.

Enrollment

334 patients

Sex

All

Ages

3 to 9 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children between the ages of 3-9 years who have had at least 2 asthma diagnoses within the last 2 years.
  • Control subjects will be age matched and without an asthma diagnosis.

Exclusion criteria

  • Children without accessible medical records

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems